Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Motif Bio’s antibiotic granted US priority review

pharmatimesAugust 15, 2018

Tag: Motif Bio , iclaprim , ABSSSI

PharmaSources Customer Service